From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Psychiatry>
  4. Summary and Comment

Stimulants and Stabilizers for ADHD and Bipolar Disorder

Stimulant use did not appear to worsen mania, but it did improve ADHD symptoms in children with hyperactivity and bipolar disorders.

In a recent chart-review study (Journal Watch Psychiatry Oct 6 2004), pediatric patients with bipolar disorder and attention deficit hyperactivity disorder had poor outcomes after treatment with mood stabilizers. In a new study, researchers investigated whether adding treatment with stimulants to treat the comorbid ADHD would improve outcome.

Forty subjects with the two disorders (mean age, 9 years) were treated openly with divalproex for 8 weeks (mood-stabilization phase). The 32 subjects (80%) who had at least a 50% decrease in mood-scale scores then entered into a randomized, double-blind, crossover trial of add-on mixed amphetamine salts (10 mg/day) or placebo; each crossover arm lasted 2 weeks. After the crossover phase, the researchers conducted a 12-week follow-up phase with open treatment using both medications to determine longer-term safety and efficacy.

At the end of the mood-stabilization phase, three subjects (7.5%) met criteria for ADHD response, compared with 26 (89.6%) after the crossover phase. In the crossover phase, mania ratings did not differ significantly between the amphetamine and placebo arms. During the follow-up phase, the mean amphetamine dosage increased to 14.5 mg/day. Only one subject experienced a worsening of mania, and the mania reversed when amphetamine was discontinued.

Comment: Previous concerns about the possibility of worsening mania with stimulant use were largely based on case reports and retrospective studies and on the theory that psychotic behaviors might worsen by using stimulants that in part block dopamine reuptake at the transporter, thus increasing available dopamine. The compelling findings of the current study support considering the use of stimulants in addition to mood stabilizers for children who have symptoms of both bipolar and hyperactivity disorders.

— Barbara Geller, MD

Published in Journal Watch Psychiatry February 24, 2005

Citation(s):

Scheffer RE et al. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. Am J Psychiatry 2005 Jan; 162:58-64.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2005. Massachusetts Medical Society. All rights reserved.